Catonsville-Based Profectus BioSciences Inc. Awarded $300K Grant
June 21, 2007
Profectus BioSciences Inc., a biotechnology company located at the University of Maryland, Baltimore County, Techcenter in Catonsville, announced it has been awarded an approximately $300,000 grant by the National Institutes of Health, Division of AIDS, to support the development of enhanced adjuvants — substances that speed up the effectiveness of medicines — used in the treatment of HIV/AIDS and other viruses. Profectus, a spinoff from the University of Maryland Biotechnology Institute, identifies and commercializes technologies to reduce the morbidity and mortality caused by viral diseases.
(c) 2007 The Daily Record (Baltimore). Provided by ProQuest Information and Learning. All rights Reserved.